Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Follicular lymphoma treatment can benefit patients 80 years and older

Key clinical point: In a cohort of FL patients aged 80 years or older, FL-directed therapy was associated with an overall survival benefit.

Major finding: Median overall survival for the treated group was 4.31 years vs. 2.86 years for the untreated group.

Study details: A retrospective database cohort study of 3,705 patients aged 80+ years, diagnosed with FL between 2000 and 2013.

Disclosures: Financial support for this study was provided by independent research funding from Bayer. One of the authors is employed by Bayer.


Albarmawi H et al. J Geriatric Oncol. 2020;11:55-61.